Werewolf Therapeutics HOWL
NASDAQ HOWL
$0.96 0.00 (-0.09%)
As of: Sep 10, 2026 · 3:53 PM EDT

Werewolf Therapeutics (HOWL) Interest Coverage Ratio (2023 - 2026)

Werewolf Therapeutics' (HOWL) quarterly Interest Coverage Ratio came in at 15.07 in Q2 2026, up 211.76% year-over-year from 4.83 in Q2 2025, and up 255.34% quarter-over-quarter from 9.7 in Q1 2026.

Analysis

Werewolf Therapeutics (HOWL) Interest Coverage Ratio (2023 - 2026) Analysis & Trends

Werewolf Therapeutics (HOWL) has reported Interest Coverage Ratio for 4 consecutive years, with 15.07 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Interest Coverage Ratio rose 211.76% year-over-year to 15.07 in Q2 2026; TTM through Jun 2026 was 6.87, a 52.28% increase from a year earlier, with the FY2025 full-year figure at 11.5, up 27.21% from the prior year.
  • Interest Coverage Ratio was 15.07 for Q2 2026 at Werewolf Therapeutics, up from 9.7 in the prior quarter.
  • Over five years, Interest Coverage Ratio peaked at 15.07 in Q2 2026 and troughed at 71.06 in Q1 2023.
  • A 4-year average of 14.57 and a median of 13.16 in 2025 frame the typical range for Interest Coverage Ratio.
  • Across the five-year window, Interest Coverage Ratio slumped 161.34% in 2024 and surged 211.76% in 2026, its largest moves.
  • Over 4 years, Interest Coverage Ratio stood at 12.83 in 2023, then declined by 25.14% to 16.06 in 2024, then soared by 57.16% to 6.88 in 2025, then soared by 319.05% to 15.07 in 2026.
  • The last three Interest Coverage Ratio figures came in at 15.07 (Q2 2026), 9.7 (Q1 2026), and 6.88 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Amgen 206.58 Bn 192.59 Bn 7.24 Bn 5.22
2 Gilead Sciences 180.17 Bn 176.99 Bn 6.22 Bn -42.08
3 Vertex Pharmaceuticals 130.59 Bn 122.74 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.61 Bn 73.61 Bn 3.93 Bn 117.59
5 Argenx Se 60.24 Bn 55.05 Bn 1.37 Bn 493.00
6 Moderna 54.29 Bn 49.15 Bn 52.00 Mn -
7 Alnylam Pharmaceuticals 32.96 Bn 29.65 Bn 992.69 Mn 2.82
8 Biogen 31.94 Bn 30.66 Bn 1.96 Bn -
9 Roivant Sciences 29.38 Bn 29.38 Bn 1.16 Mn -
10 Werewolf Therapeutics 46.85 Mn 46.85 Mn - 15.07
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.07
Mar 31, 2026 -9.70
Dec 31, 2025 -6.88
Sep 30, 2025 -11.73
Jun 30, 2025 -13.48
Mar 31, 2025 -14.24
Dec 31, 2024 -16.06
Sep 30, 2024 -13.77
Jun 30, 2024 -16.60
Mar 31, 2024 -17.11
Dec 31, 2023 -12.83
Sep 30, 2023 -9.23
Jun 30, 2023 -6.35
Mar 31, 2023 -71.06